Status | Study |
Recruiting |
Study Name: Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP) Condition: Ventilator-associated Pneumonia Date: 2014-02-27 Interventions: Drug: Chlorhexidine |
Completed |
Study Name: Diagnostic Value of Lung Ultrasound for Ventilator-Associated Pneumonia Condition: Ventilator-Associated Pneumonia Date: 2013-09-05 Interventions: Other: Lung ultrasound examination Lung ultrasound (LUS) is increasingly being used at the bedside for a |
Completed |
Study Name: Can we Better Understand the Development of VAP and Eventually Predict and Prevent it? Condition: Pneumonia, Ventilator-Associated Date: 2013-03-15 |
Completed |
Study Name: Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients Condition: Ventilator Associated Pneumonia Date: 2011-12-12 Interventions: Device: Taper Guard Endotracheal Tube |
Completed |
Study Name: The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia Condition: Ventilator-Associated Pneumonia Date: 2011-11-23 Interventions: Drug: Imipenem 0.5 g of imipen |
Completed |
Study Name: The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia Condition: Ventilator-Associated Pneumonia Date: 2011-10-31 Interventions: Drug: Doripenem |
Recruiting |
Study Name: Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia Condition: Methicillin-resistant Staphylococcus Aureus Pneumonia, Ventilator-Asso Date: 2011-05-17 Interventions: Drug: Imipenem/cilastatin the intervention group was designed for combined linezolid plus imipenem for t |
Completed |
Study Name: Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia Condition: Ventilator Associated Pneumonia Date: 2011-05-05 Interventions: Drug: Imipenem Each patient wi |
Withdrawn |
Study Name: Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients Condition: Ventilator Associated Pneumonia Date: 2010-05-04 Interventions: Drug: Sultamicillin Ampoules per 1.5 grams, three grams intravenously every 6 hours for 4 doses diluted |
Terminated |
Study Name: Ventilator-Associated Pneumonia (VAP) in Intensive Care Unit (ICU) Condition: Ventilator-Associated Pneumonia Date: 2009-07-08 |